Assistant Professor in clinical epidemiology at Karolinska Institutet and junior physician at the Department of Endocrinology, Karolinska University Hospital and Center for Diabetes, Stockholm Region.
Obtained medical degree and a PhD in epidemiology at Karolinska Institutet and was a post-doctoral researcher at Harvard TH Chan School of Public Health.
Current research focus include pharmacoepidemiological studies on glucose-lowering drugs, cholesterol-lowering drugs and dual antiplatelet therapy as well as cardiovascular risk prediction.
Take-home messages: glucose-lowering medication after myocardial infarction in hospital and after discharge.
Event: ESC Congress 2022
Topic: Risk Factors and Prevention
Session: What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge
